3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Carcinoma
6
Lung Neoplasms
5
Nasopharyngeal Carcinoma
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ganglioneuroblastoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Neuroblastoma
1
Mesothelioma
1
Medulloblastoma
1
Locally Advanced Cervical Adenocarcinoma
1
Liver Neoplasms
1
Interventions
Cyclophosphamide
11
fludarabine
8
Dexamethasone
7
pomalidomide
6
pembrolizumab
6
Rituximab
5
obinutuzumab
4
glofitamab
4
daratumumab
4
Immunotherapy, Adoptive
4
Gemcitabine
4
Bortezomib
4
venetoclax
3
selinexor
3
fludarabine phosphate
3
cemiplimab
3
Temozolomide
3
Nivolumab
3
Melphalan
3
Injections
3
Etoposide
3
zanubrutinib
2
tocilizumab
2
pirtobrutinib
2
blinatumomab
2
abemaciclib
2
Sirolimus
2
Oxaliplatin
2
Mesna
2
Lisaftoclax
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
1,2-diaminocyclohexaneplatinum II citrate
×
30 days
×
Clear all
No trials found.